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Abstract We investigated the occurrence and the role of HSF1
activation and inducible hsp72 expression in the carrageenin
pleurisy in the rat. Molecular analysis performed on pleural cells
collected from rat pleural cavity after carrageenin challenge
revealed increased HSF1 activation and hsp72 expression.
Moreover, local injection of a double-stranded oligodeoxynucleo-
tide (ODN) containing the heat shock element sequence, acting
as transcription factor decoy, exacerbated the inflammatory
reaction. The exacerbation, induced by wild-type, but not by
mutant ODN decoy, was associated to both inhibition of HSF1/
DNA binding activity and reduction of hsp72 expression. In
conclusion, this study shows that HSF1 activation and hsp72
expression both actually occur in acute inflammation and that
the remission of the inflammatory reaction is tightly associated
to the HSF1-dependent hsp72 expression, suggesting a a relevant
role for the HSF1/hsp72 pathway as an endogenous anti-
inflammatory system. ß 2001 Federation of European Bio-
chemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
The overall biological signi¢cance of in£ammation is that of
a defence response. However, the in£ammatory reaction may
be harmful unless kept under control and driven to remission
by cytoprotective mechanisms, collectively termed homeosta-
sis. One of the most relevant of these mechanisms is the syn-
thesis of stress-induced or heat shock proteins (hsp), of which
hsp70 exhibits a cytoprotective role in a wide variety of hu-
man diseases [1,2]. Regulation of hsp genes requires the acti-
vation and the translocation to the nucleus of a transregula-
tory protein, the heat shock transcription factor (HSF), which
binds to multiple arrays of heat shock elements (HSEs) lo-
cated in the promoter region of heat shock genes [2]. The
recent cloning of HSF genes in higher eukaryotes has revealed
a family of HSFs (from HSF1 to HSF4), but is essentially
HSF1 that is activated by various kinds of stress. In the cy-
toplasm, HSF1 is constitutively present in a non-DNA bind-
ing state, which is rapidly converted to the DNA binding form
upon exposure to heat shock or other environmental stimuli
[3]. HSF1 activation requires trimerisation, acquisition of
DNA binding activity, translocation to the nucleus and induc-
ible serine phosphorylation, resulting in stress-induced tran-
scription of heat shock proteins [3].
The wealth of information on the defensive role of the
hsp70 family has been so far almost exclusively derived from
in vitro systems and there is so far little evidence in vivo of
HSF1 activation and/or hsp72 expression in in£ammatory
cells or in£amed tissues. Since in£ammation is often associ-
ated with local increase in temperature it may be conceivable
that HSF1 activation and hsp72 expression may both occur
during an in£ammatory reaction.
Recent reports have shown that synthetic double-stranded
phosphorothioate oligodeoxynucleotides (ODNs) may act as
decoy cis elements blocking the binding of transcription fac-
tors to promoter regions of their targeted genes and resulting
in the inhibition of gene transactivation both in vitro [4,5] and
in vivo [6^8]. Thus, we used the decoy strategy as a tool for
investigating the role of HSF1 in in£ammation.
In the present study we show that HSF1 activation actually
occurs in rat carrageenin-induced pleurisy, a model of acute
in£ammation characterised by exudate formation and cell mi-
gration. Furthermore, our results provide evidence, for the
¢rst time to our knowledge, that the remission of the in£am-
matory reaction is closely associated to the HSF1-dependent
expression of hsp72, since administration of double-stranded
ODN decoy to HSF1 inhibits HSF1 activation, reduces hsp72
expression and exacerbates the in£ammatory reaction.
2. Materials and methods
2.1. Animals
Male Wistar rats (Harlan, Italy) weighing 175^200 g were used in
all experiments. Animals were provided with food and water ad libi-
tum. The light cycle was automatically controlled (on 07 h, o¡ 19 h)
and the room temperature thermostatically regulated to 22 þ 1‡C. Pri-
or to the experiments animals were housed in these conditions for 3^4
days to become acclimatised. Animal care was in accordance with
Italian and European regulations on the protection of animals used
for experimental and other scienti¢c purposes.
2.2. Induction of pleurisy
Animals were slightly anaesthetised with iso£uorane (Abbott) and
0.2 ml sterile saline solution or 1% V-carrageenin (Sigma) suspended
in sterile saline were injected into the right pleural cavity. Animals
were sacri¢ced 2, 6, 12, 24 and 48 h after the induction of pleurisy in
an atmosphere of CO2. Pleural exudate from each animal was har-
vested by washing the pleural cavity with 2 ml of sterile saline con-
taining 5 U/ml heparin (Sigma). Any exudate with blood contamina-
tion was rejected. The exudate volumes were measured and results
were expressed by subtracting the volume (2 ml of sterile saline) in-
jected in the pleural cavity from total volume recovered. Each exudate
sample was then centrifuged at 800Ug for 10 min and cell pellet
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resuspended in saline. Total cell count in each sample was estimated
after trypan blue staining using a Burker counting chamber. In some
experiments di¡erential cell count was determined in smears by May^
Grunwald staining. In some experiments, groups of animals, 24 h
after carrageenin injection, received a single pleural injection of
3 nmol of wild-type ODN (wt-ODN) or mutant ODN (mut-ODN)
in 0.1 ml of sterile saline, while control rats received saline alone.
Then, 24 h later, rats were sacri¢ced and pleural exudates collected
and processed as described above.
2.3. Transcription factors decoy oligonucleotides
The ODNs used in this study were synthesised as phosphorothioate
derivatives, which are resistant to degradation by endonucleases, to
our speci¢cations by Tib Molbiol Roche Biochemical. Double-
stranded phosphorothioate ODN decoy to HSF1 was prepared by
annealing of sense and antisense oligonucleotides in vitro in 1U an-
nealing bu¡er. The mixture was heated at 100‡C for 12 min and
allowed to cool to room temperature slowly over 18 h.
The phosphorothioate ODN sequences used in this study were: 5P-
CTA GAA GCT TCT AGA AGC TTC TAG-3P for wild-type HSF
ODN decoy and 5P-ATA TCC GCA GGT ATC GGC AGT TAG-3P
for mutant HSF ODN decoy.
2.4. Preparation of cell extracts
All the extraction procedures were performed on ice with ice-cold
reagents. Cells were separated from the in£ammatory exudate by cen-
trifugation at 800Ug for 5 min at 4‡C. In£ammatory cell pellets were
washed twice in phosphate-bu¡ered saline (PBS; ICN Biomedicals)
and centrifuged at 800Ug for 5 min at 4‡C. Whole cell extracts were
prepared by resuspending the pellet in one packed cell volume of a
high-salt extraction bu¡er and incubated on ice for 15 min. After
centrifugation at 13 000Ug at 4‡C for 5 min, the protein concentra-
tion in the supernatant was determined by the Bio-Rad protein assay
kit and then it was aliquoted and stored at 380‡C.
Nuclear extracts were prepared as previously described [9]. Protein
concentration was determined by the Bio-Rad protein assay kit.
2.5. Electrophoretic mobility-shift assay (EMSA)
A double-stranded oligonucleotide containing the idealised HSE
sequence [10^12] was end-labeled with [Q-32P]ATP (ICN Biomedicals)
and gel mobility assay was performed as described [12]. Aliquots of
nuclear extracts (15 Wg protein for each sample) were incubated for 30
min with radiolabeled oligonucleotides (2.5^5.0U104 cpm) in 20 Wl
reaction bu¡er containing 2 Wg poly dI-dC (Roche Biochemicals),
10 mM Tris^HCl (pH 7.5), 100 mM NaCl, 1 mM EDTA, 1 mM
dithiothreitol, 1 mg/ml bovine serum albumin, 10% v/v glycerol. The
speci¢city of the DNA/protein binding was determined by competi-
tion reaction in which a 50-fold molar excess of unlabeled wild-type,
mutant or Oct-1 oligonucleotide was added to the binding reaction 10
min before addition of radiolabeled probe. In supershift assay, anti-
bodies reactive to HSF1 (StressGen) or HSF2 (LabVision) proteins
were added to the reaction mixture 30 min before the addition of
radiolabeled HSF1 probe. Recombinant human HSF1 protein (Stress-
Gen) was used as positive control. Protein^nucleic acid complexes
were resolved by electrophoresis on 4% non-denaturing polyacryl-
amide at 150 V for 2 h at 4‡C. The gel was dried and autoradio-
graphed with intensifying screen at 380‡C for 20 h. Subsequently, the
relative bands were quanti¢ed by densitometric scanning of the X-ray
¢lms with a GS-700 Imaging Densitometer (Bio-Rad) and a computer
program (Molecular Analyst, IBM).
2.6. Immunoprecipitation and Western blot analysis
The level of hsp72 was quanti¢ed in whole cell extract, by immu-
noprecipitation followed by Western blot analysis according to the
manufacturer’s instructions (Santa Cruz). Brie£y, equivalent amounts
of whole cell extracts (100 Wg for each sample) were mixed with 40 Wl
of protein A-Sepharose and 2 Wl of anti-hsp72 polyclonal antibody
(StressGen) which speci¢cally recognises the inducible but not the
constitutive members of the hsp70 family and left overnight at 4‡C
with continuous shaking. Immunocomplexes were washed three times
with 500 Wl of bu¡er A (10 mM Tris^HCl pH 7.5, 1 M NaCl, 0.2%
Triton X-100 and 2 mM EDTA), mixed with 40 Wl of gel loading
bu¡er (50 mM Tris/10% sodium dodecyl sulphate/10% glycerol/10%
2-mercaptoethanol/2 mg bromophenol per ml) and then boiled for
3 min. Samples so obtained were electrophoresed in a 10% discontin-
uous polyacrylamide minigel. The proteins were transferred onto ni-
trocellulose membranes, according to the manufacturer’s instructions
(Bio-Rad). The membranes were saturated by incubation at 4‡C over-
night with 10% non-fat dry milk in PBS and then incubated with anti-
hsp72 antibody for 1 h at room temperature. The membranes were
washed three times with 1% Triton X-100 in PBS and then incubated
with anti-rabbit immunoglobulin coupled to peroxidase. The immu-
nocomplexes were visualised by the ECL chemiluminescence method
(Amersham). Subsequently, the relative expression of hsp72 was quan-
ti¢ed by densitometric scanning of the X-ray ¢lms with a GS-700
Imaging Densitometer (Bio-Rad) and a computer program (Molecular
Analyst, IBM).
2.7. Statistics
Data are expressed as mean þ S.E.M. for n rats. Statistical analysis
was done using an ANOVA followed by a Bonferroni t-test. The level
of statistically signi¢cant di¡erence was de¢ned as P6 0.05.
3. Results
3.1. Time course of exudate volume and cellular in¢ltration
The pleural cavity of normal (untreated) rats contained no
exudate and 2.9 þ 0.2U106 cells per rat (n = 5) predominantly
mononuclear (s 95%). Injection of 0.2 ml of 1% V-carragee-
nin into the pleural cavity of rats caused an in£ammatory
response characterised by exudate formation and cell migra-
tion (Fig. 1). Both the exudate volume and the total leukocyte
number migrated into the pleural cavity increased with time,
reached the maximum at 24 h (1.57 þ 0.10 ml/rat and
90.6 þ 6.9U106cells/rat, n = 9), and decreased at 48 h (0.30 þ
0.05 ml/rat and 39.9 þ 3.8U106 cells/rat, n = 10). Di¡erential
cell count of leukocytes migrated into the pleural cavity
Fig. 1. Time course of rat carrageenin pleurisy. Exudate volume (A)
and leukocyte in¢ltration (B) were evaluated at di¡erent time points
after carrageenin injection. The values are expressed as mean þ
S.E.M. of 7^10 rats.
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showed that polymorphonuclear leukocytes dominated the
early phase (2 h) of the reaction (91% of polymorphonuclear
leukocytes and 19% of mononuclear leukocytes) and were
replaced at 48 h by mononuclear leukocytes (29% of polymor-
phonuclear leukocytes and 71% of mononuclear leukocytes).
3.2. Time course of HSF binding activity and hsp72 protein
expression
To detect HSF/DNA binding activity, an EMSA was per-
formed by using nuclear extracts from pleural cells collected
from normal rats or at di¡erent time points (2, 6, 12, 24, 48 h)
after carrageenin challenge and a labeled oligonucleotide con-
taining the idealised HSE sequence. As shown in Fig. 2, a
retarded band of DNA^protein complex was faintly detected
either in normal rats or in the early phase (2, 6 and 12 h) of
carrageenin pleurisy, while it was clearly detected at 24 h and
at 48 h.
We also investigated the presence of hsp72 in the whole
fractions of pleural cells collected from normal rats or from
carrageenin-treated rats at di¡erent time points (2, 6, 12, 24
and 48 h) after induction of the pleurisy. Western blot anal-
ysis and its relative densitometric analysis showed a time-de-
pendent increase of hsp72 protein levels in whole extracts of
pleural cells from carrageenin-challenged rats as compared to
normal rats (Fig. 3).
3.3. Characterisation of HSF complex induced by carrageenin
in rat pleural cells
In order to con¢rm the speci¢city of the HSF/DNA com-
plex activated by carrageenin we performed experiments of
competition and supershift (Fig. 4). The speci¢city of HSF/
DNA binding complex was demonstrated by the complete
Fig. 2. Time course of HSF/DNA binding activity. EMSA was per-
formed on nuclear extracts from rat pleural cells collected either
from normal rats (N) or from carrageenin-treated rats at di¡erent
time points (2, 6, 12, 24 and 48 h) after pleural injection. EMSA in
A is from a single experiment and is representative of three separate
experiments. Results of densitometric analysis in B are expressed as
mean þ S.E.M. of three separate experiments.
Fig. 3. Time course of hsp72 expression. Immunoblotting analysis
was performed in whole extracts from rat pleural cells collected ei-
ther from normal rats (N) or from carrageenin-treated rats at di¡er-
ent time points (2, 6, 12, 24 and 48 h) after pleural injection. West-
ern blot in A is from a single experiment and is representative of
three separate experiments. Results of densitometric analysis in B
are expressed as mean þ S.E.M. of three separate experiments.
Fig. 4. Identi¢cation of carrageenin-induced HSF1/DNA binding activity. Nuclear extracts from carrageenin-elicited in£ammatory cells were
prepared as described in the text and incubated with 32P-labeled HSF probe. In competition reaction nuclear extracts were incubated with ra-
diolabeled HSF probe in the absence or presence of a 50-fold molar excess of identical but unlabeled HSF probe (W.T. 50U), mutated non-
functional HSF probe (Mut. 50U) or unlabeled oligonucleotide containing the consensus sequence for Oct-1 (Oct-1 50U). In supershift experi-
ments nuclear extracts were incubated with antibodies against HSF1 or HSF2 30 min before incubation with radiolabeled HSF probe.
PC = positive control. Data illustrated are from a single experiment and are representative of three separate experiments.
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displacement of the HSF/DNA binding in the presence of a
50-fold molar excess of unlabeled HSF probe in the competi-
tion reaction. In contrast, a 50-fold molar excess of unlabeled
mutated HSF probe or Oct-1 oligonucleotide had no e¡ect on
this DNA binding activity. Furthermore, to establish which
member of the HSF family was activated by carrageenin,
nuclear cell extracts were preincubated with speci¢c antibodies
for either HSF1 or HSF2 and analysed by EMSA. Addition
of anti-HSF1 but not anti-HSF2 to the binding reaction re-
sulted in a supershift of HSF band, thus indicating that car-
rageenin induces HSF1/DNA binding activity (Fig. 4).
3.4. E¡ect of ODN decoy on carrageenin-induced rat pleurisy
In preliminary experiments we established that injection
into the rat pleural cavity of test agents at doses used in
this study did not produce any detectable e¡ect. The average
volume of the exudate at 48 h in control animals (carrageenin
alone) was 0.25 þ 0.04 ml/rat (n = 9) and the total leukocytes
number into the pleural cavity was 36.33 þ 3.12U106cells/rat
(n = 9). The injection into the pleural cavity of wt-ODN decoy
(3 nmol/site), given 24 h after carrageenin challenge, sig-
ni¢cantly increased both exudate volume to 0.78 þ 0.06 ml/rat
(P6 0.01; n = 9) and total leukocytes number to
70 þ 3.5U106cells/rat (P6 0.01; n = 9). In contrast, mut-
ODN decoy (n = 6) given at the same dose and time as the
wild-type had no e¡ect (Fig. 5A,B). Furthermore, neither wt-
ODN nor mut-ODN decoy a¡ected the pro¢le of cell popu-
lation in the exudate £uid which resulted virtually superim-
posable to that found in control rats, i.e. animal receiving
carrageenin alone (see Section 3.1). Thus, 48 h after carra-
geenin injection the pleural exudate from rats treated with
wt-ODN (3 nmol/site, n = 6) contained 25% of polymorpho-
nuclear leukocytes and 75% of mononuclear leukocytes, while
the exudate from rats treated with mut-ODN (3 nmol/site,
n = 6) contained 28% of polymorphonuclear leukocytes and
72% of mononuclear leukocytes.
3.5. E¡ect of ODN decoy on HSF1 activation and hsp72
expression in pleural cells
To detect HSF1/DNA binding activity nuclear extracts
from pleural cells collected 48 h after carrageenin injection
were analysed by EMSA. Treatment of rats with wt-ODN
(3 nmol/site; n = 9) caused a signi¢cant (P6 0.01) inhibition
of carrageenin-induced HSF1/DNA binding activity by 42%
(Fig. 5C). In contrast, mut-ODN (3 nmol/site ; n = 6) did not
modify carrageenin-induced HSF1/DNA binding activity as
compared to control animals (Fig. 5C).
The levels of hsp72 from pleural cells collected 48 h after
carrageenin injection were examined by immunoblotting anal-
ysis. Injection of wt-ODN (3 nmol/site ; n = 9) signi¢cantly
(P6 0.01) reduced hsp72 band intensity by 63% (Fig. 5D).
In contrast, mut-ODN (3 nmol/site; n = 6) had no e¡ect on
carrageenin-induced increase of hsp72 levels as compared to
control group (Fig. 5D).
Fig. 5. E¡ect of ODN decoy on rat carrageenin pleurisy, HSF1/DNA binding activity and hsp72 protein expression. wt-ODN decoy (3 nmol/
site) and mut-ODN decoy (3 nmol/site) were injected into the pleural cavity of rats 24 h after carrageenin injection. Exudate volume (A) and
leukocyte migration (B) were evaluated 48 h after carrageenin challenge. Densitometric analysis of HSF1/DNA binding activity measured by
EMSA (C) and of hsp72 protein expression measured by Western blot (D) were evaluated in in£ammatory cells collected 48 h after carrageenin
challenge. Results in A and B are expressed as mean þ S.E.M. of 6^9 rats. Results in C and D are expressed as mean þ S.E.M. of three separate
experiments. **P6 0.01 vs control group (C).
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4. Discussion
In this study we demonstrate that HSF1-dependent hsp72
expression occurs in rat carrageenin pleurisy, a model of acute
in£ammation. Both HSF1 and hsp72 appear in in£ammatory
cells collected from the pleural exudate at the late phase of the
reaction and are closely associated to and likely control the
remission of the process. Moreover, in the present study we
report a novel experimental approach to the study of the
in£ammatory response, i.e. in vivo administration of a decoy
cis element to bind the transcription factor HSF1. Our results
show that injection into the rat pleural cavity of double-
stranded ODN as decoy, by competitively inhibiting the bind-
ing of HSF1 to native DNA sequence, reduced hsp72 expres-
sion and exacerbated carrageenin-induced pleurisy, suggesting
a relevant role of the HSF1/hsp72 pathway as an endogenous
anti-in£ammatory system. The speci¢city of the e¡ect of ODN
decoy to HSF1 is supported by evidence showing that ODN
decoy with a mutated HSF1 consensus sequence does not
a¡ect carrageenin-induced pleurisy.
Heat shock proteins, particularly hsp70, act as molecular
chaperones, have well established functions in protecting cells,
and are responsible for thermotolerance and acquired resis-
tance to other forms of injury. Thus, recently it has been
shown that pretreatment of rats with a mild heat shock im-
proved recovery from ischemia of perfused rat hearts [13].
Similarly, in rats submitted to heat shock 24 h earlier, a de-
crease in myocardial infarct size occurred in comparison to
control animals [14].
Since in our experimental protocol rats did not receive any
kind of heat shock, the activation of the HSF1/hsp72 system
has been caused only by the stress due to the in£ammatory
stimulus.
A question that rises from this study is how can in£amma-
tion induce the activation of the HSF1/hsp72 system. It has
been speculated that heat shock proteins themselves may reg-
ulate heat shock gene expression via an autoregulatory loop
[15]. According to this hypothesis, misfolded proteins occur-
ring in large amounts during heat shock or other forms of
stress might sequester hsp70 and lead to activation of HSF1.
Support for this autoregulatory hypothesis comes from the
observation that inactive HSF1 in cytoplasmic extracts from
non-heat-shocked HeLa cells can be converted to the DNA
binding state by exposure to environmental stress such as
heat, non-ionic detergents or low pH [16,17], whereas the
addition of hsp70 blocks this conversion [18].
However, it has recently been shown, in rheumatoid arthri-
tis synovial tissue [19], that pro-in£ammatory cytokines, such
as tumour necrosis factor-K, interleukin (IL)-6 and IL-1,
which are highly expressed in rat carrageenin-induced pleurisy
[20], induce HSF1 activation and hsp72 expression. Moreover,
it has been demonstrated that cyclooxygenase (COX) cyclo-
pentenone metabolites such as prostaglandins of the A and J
type induce the synthesis of hsp70 in a wide variety of human
and mammalian cells [21]. Furthermore, it has also been
shown that cyclopentenone prostaglandins are generated by
COX-2 during the late phase of carrageenin pleurisy in rats
and contribute to the resolution of the in£ammatory reaction
through not yet identi¢ed molecular mechanisms [22]. In this
light it is conceivable to hypothesise that the activation of
HSF1, occurring during the late phase of carrageenin pleurisy,
may be induced by cyclopentenone prostaglandins.
Although the anti-in£ammatory mechanism of hsp72 has
not been clari¢ed yet we may hypothesise that in our system
this protein may drive the in£ammatory reaction to the reso-
lution by protecting mononuclear leukocytes which are known
to produce endogenous anti-in£ammatory molecules such as
TGF-L, IL-10 and cyclopentenone prostaglandins [22^24].
Further studies will clarify this hypothesis.
Another important issue addressed by our study is the
demonstration that ODN decoy strategy can be used in
vivo for investigating the in£ammatory reaction. Thus, our
results demonstrated that the inhibition of hsp genes expres-
sion results in exacerbation of the in£ammatory process.
Therefore these genes may be considered as anti-in£ammatory
or ‘therapeutic’ genes, and their selective in vivo transactiva-
tion, by appropriate pharmacological agents, may lead to the
remission of the in£ammatory reaction. In conclusion, our
results suggest that the HSF1/hsp72 pathway may represent
an endogenous anti-in£ammatory system whose activation
protects the organism from the deleterious e¡ects of a pro-
longed and excessive activation of the in£ammatory response.
Moreover, the transcription factor decoy strategy, by interfer-
ing with the activation and expression of selected genes, may
represent a useful tool for a better comprehension of the in-
£ammatory process as well as for future therapeutic ap-
proaches.
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